UMB Bank n.a. Has $678,000 Position in CVS Health Co. (NYSE:CVS)

UMB Bank n.a. decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 18.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,107 shares of the pharmacy operator’s stock after selling 3,507 shares during the quarter. UMB Bank n.a.’s holdings in CVS Health were worth $678,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. ProShare Advisors LLC boosted its stake in shares of CVS Health by 9.0% during the 2nd quarter. ProShare Advisors LLC now owns 209,881 shares of the pharmacy operator’s stock valued at $12,396,000 after buying an additional 17,281 shares during the period. Frank Rimerman Advisors LLC boosted its position in CVS Health by 9,318.2% during the second quarter. Frank Rimerman Advisors LLC now owns 9,324 shares of the pharmacy operator’s stock valued at $551,000 after purchasing an additional 9,225 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in CVS Health by 12.6% in the second quarter. EverSource Wealth Advisors LLC now owns 15,618 shares of the pharmacy operator’s stock valued at $942,000 after purchasing an additional 1,753 shares in the last quarter. Lombard Odier Asset Management Europe Ltd raised its stake in shares of CVS Health by 29.9% during the 2nd quarter. Lombard Odier Asset Management Europe Ltd now owns 30,099 shares of the pharmacy operator’s stock worth $1,778,000 after purchasing an additional 6,927 shares in the last quarter. Finally, Bank of Montreal Can lifted its holdings in shares of CVS Health by 2.4% during the 2nd quarter. Bank of Montreal Can now owns 2,436,343 shares of the pharmacy operator’s stock valued at $143,890,000 after buying an additional 57,214 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CVS has been the subject of a number of analyst reports. Mizuho reduced their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. TD Cowen upped their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a research note on Tuesday, December 3rd. Finally, Evercore ISI boosted their target price on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Stock Up 1.0 %

NYSE CVS opened at $53.14 on Wednesday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The stock has a market cap of $66.87 billion, a PE ratio of 13.49, a PEG ratio of 0.79 and a beta of 0.59. The firm has a 50-day simple moving average of $51.27 and a 200 day simple moving average of $56.29. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same period in the previous year, the business earned $2.21 EPS. The firm’s revenue was up 6.3% on a year-over-year basis. On average, research analysts forecast that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 5.01%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.